Lab Automation market Professional Survey Report by 2035 The rising demand for greater data reproducibility, accuracy and increased efficiency have prompted the healthcare laboratories to consider shifting from manually-handled processes to using lab automation systems. Roots Analysis is pleased to announce the publication of its recent study, titled, “Lab Automation Market, 2023-2035” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these lab automation systems over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed assessment of the current market landscape of lab automation system manufacturers engaged in the manufacturing of various lab automation systems.  A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength, product diversity and product strength.  Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation system across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.  A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.  An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).  A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software, mode(s) of deployment, end-user(s).  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Stage of Automation  Pre-Analytical Stage  Analytical Stage  Post-Analytical Stage  Total Lab Automation  Type of Instrument  Automated Liquid Handling Systems  Automated Microplate Readers  Automated Sampling Systems  Analyzers  Automated Storage and Retrieval Systems (ASRS)  Other Instruments  End-User  Pharmaceutical and Biotechnology Companies  Research and Diagnostic Laboratories  Other End-Users  Key Geographical Region  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America Key companies covered in the report  Abbott  Anton Paar  BD  Beckman Coulter  ERWEKA  Leuze  Ortho Clinical Diagnostics  Pall Corporation  PerkinElmer  Roche Diagnostics  Siemens Healthineers  SYSTAG To view more details on this report, click on the link https://www.rootsanalysis.com/reports/lab-automation-market.html News article Digital Biomanufacturing Market Learn from experts: do you know about these emerging industry trends? SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases Novel Cell Cytometers: Need of the Hour Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #LabAutomationMarket #LabAutomationMarketGrowth #labautomation #laboratoryautomation #laboratoryautomationmarket

Viral Clearance and Viral Testing Services market Growth Analysis by 2035 As per Roots Analysis - with the growing pipeline of biologics and the continuous revision of regulatory guidelines, the demand for viral clearance and testing services has increased in the biopharmaceutical industry. As a result, biopharmaceutical developers are outsourcing their viral clearance and testing operations to reliable and specialized contract research organizations (CROs), which provide a plethora of advanced technologies and dedicated expertise to cater to their evolving needs. The financial opportunity within the viral clearance market has been analyzed across the following segments:  Scale of Operation  Discovery Phase  Preclinical Phase  Clinical Phase  Method of Viral Clearance and Testing  Viral Detection  Viral Inactivation  Viral Removal  End-User  Biotechnology and Pharmaceutical Companies  Academic / Research Institutes  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World The “Viral Clearance Testing Services Market, 2023 – 2035” report features the following companies, which we identified to be key players in this domain:  Charles River Laboratories  Eurofins Scientific  Microbac Laboratories  Nelson Labs  Pall Corporation  Syngene International  Texcell Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Viral Clearance and Testing Service Providers: Market Landscape 5. Company Competitiveness Analysis 6. Viral Clearance and Testing Service Providers in North America 7. Viral Clearance and Testing Service Providers in Europe and Asia-Pacific 8. Patent Analysis 9. Recent Developments 10. Viral Clearance and Testing Services: Market Forecast and Opportunity Analysis 11. Conclusion 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/viral-clearance-and-testing-services-market.html News article AI-based digital pathology market Learn from experts: do you know about these emerging industry trends? TIL Therapies: A New Paradigm in Cancer Treatment Applications of Blockchain in Various Sectors: An Introduction About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #ViralClearanceandViralTestingServicesMarketGrowth #ViralClearanceandViralTestingServicesMarketTrends #viralclearancetesting #viralclearancestudies #viralinactivation

mRNA therapeutics and Vaccines market Size, Share, Trends by 2035 The “mRNA Therapeutics and Vaccines Market: Industry Trends and Global Forecasts, 2022 – 2035” report features an extensive study of the current market landscape and the likely future potential associated with the biopharmaceutical contract manufacturing market, over the next decade. The study also includes an elaborate discussion on the future potential of this evolving market. Amongst other elements, the report features: Key Inclusions  A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters, such as phase of development (marketed, phase III, phase II, phase I / II, phase I, preclinical and discovery), type of drug candidate (mRNA therapeutic and mRNA vaccine), therapeutic area (infectious diseases, oncological disorders, genetic disorders, pulmonary disorders, autoimmune disorders and other disorders), type of delivery system used (lipid nanoparticles, lipopolyplex, liposomes, direct transfer, self-amplifying RNA platform and others), type of molecule encoded (spike protein, glycoprotein, antigen, cytokine, protein coding gene, tumor neoantigen, enzyme, tumor antigen and others) and route of administration (intramuscular, intravenous, intranasal and others).  A detailed overview of the current mRNA therapeutics and mRNA vaccine market of players engaged in the development of mRNA therapeutics and vaccines, along with information on their year of establishment, company size (in terms of number of employees), location of headquarters, regional landscape and key players engaged in this domain.  An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.  Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and vaccines, along with information on the development timeline of the therapy, current development status, primary target indication, therapeutic area, type of molecule encoded, type of delivery system used, affiliated technology, recent partnerships associated with the drug, clinical trial results related to the drug and other recent developmental.  A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021), featuring a [A] heat map representation that highlights mRNA therapeutics and vaccines under development (in partnership with core mRNA-focused entities), along with information on funding amount raised, partnership activity, and diversity of product portfolio (in terms of disease indication(s) being treated and focus therapeutic area(s)), as well as [B] a spider web representation, comparing the initiatives of big pharmaceutical players on the basis of multiple relevant parameters.  An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters, such as number of candidates in discovery, preclinical and clinical phases of development, amount raised, number of investors and number of deals inked.  An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters, such as trial registration year, trial status, trial phase, target therapeutic area, study design, type of sponsor / collaborator, leading industry players (in terms of number of trials conducted), enrolled patient population and key geographical regions.  An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry, based on several relevant parameters, such as year of partnership, type of partnership, targeted therapeutic area, most active players (in terms of number of deals inked) and regional distribution of partnership activity that have been undertaken in this domain, during the period 2013-2022.  A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022, based on several relevant parameters, such as year of funding, type of funding (seed financing, venture capital, IPOs, secondary offerings, debt, grants and other offerings), amount invested, therapeutic area, most active players (in terms of number of funding instances and amount invested) and key investors (in terms of number of funding instances).  An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016, based on several relevant parameters, such as type of patent (granted patents, patent applications and others), publication year, geographical region, CPC symbols, leading industry players (in terms of the number of patents filed / granted) and patent valuation. The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:  Routes of Administration  Intradermal  Intravenous  Intranasal  Others  Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa Key Questions Answered  Which are the key players engaged in the development of mRNA therapeutics and vaccines?  Which mRNA drug candidates are being evaluated across early and late stages of clinical development?  Which are the key therapeutic areas targeted by mRNA therapeutics and vaccines?  Which type of delivery systems are primarily being used for the delivery of mRNA therapeutics and vaccines?  Which are the most active trial sites (in terms of number of clinical studies being conducted) related to mRNA therapeutics and vaccines?  Which companies are actively filing patents in order to drive innovation in the field of mRNA therapeutics and vaccines?  What type of partnership models are commonly adopted by stakeholders in the mRNA therapeutics and vaccine domain?  Which are the companies that are investing heavily in this domain?  How is the current and future market opportunity likely to be distributed across the various key market segments? To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html News article Modular Facility Manufacturers Market Learn from experts: do you know about these emerging industry trends? Novel Cell Cytometers: Need of the Hour Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mRNAtherapeuticsandVaccinesMarket #mRNAtherapeuticsandVaccinesMarketSize #mrnatherapeutics #mrnavaccine #mrnavaccinemarket

Dental 3D Printing market 2023 – Industry Growth by 2035 Roots Analysis has done a detailed study on Dental 3D Printing Market, 2023 – 2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. Key Market Insights  Presently, around 230 dental 3D printers are available for use across wide range of dental applications; majority of these devices print crowns, bridges, dentures and working models  A myriad of printing technologies are currently being used by dental 3D printer manufacturers; majority of the dental 3D printers use resins as printing material  The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions; majority of these players are based in Europe and Asia-Pacific  In pursuit of gaining a competitive edge, developers are making an active effort to incorporate advanced technologies into their respective portfolios of dental 3D printers and comply with evolving industry needs  The growing interest of stakeholders is also evident from the rise in partnership activity; in fact, majority of the intracontinental agreements were signed by companies based in North America  The rising interest of various stakeholders in dental 3D printing and associated technologies has led to an increase in research, and subsequently, the expansion of intellectual capital in this domain  Cost is a key determinant of the acceptance and adoption of 3D printers in the dental industry; pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their offerings  The dental 3D printing market is expected to grow at a CAGR of 14.2% till 2035; the projected opportunity is likely to be well distributed across various market segments Table of Contents 1. PREFACE 1.1. Scope of the Report 1.2. Market Segmentation 1.3. Research Methodology 1.4. Key Questions Answered 1.5. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Chapter Overview 3.2. Overview of Dental 3D Printing 3.3. Dental 3D Printing Technologies 3.4. Applications of 3D Printing in Dental Industry 3.5. Advantages and Limitations Associated with Dental 3D Printing 3.6. Future Perspectives 4. MARKET LANDSCAPE 4.1. Chapter Overview 4.2. Dental 3D Printers: Overall Market Landscape 4.3. Dental 3D Printer Manufacturers: Developer Landscape 5. PRODUCT COMPETITIVE ANALYSIS 5.1. Chapter Overview 5.2. Assumptions and Key Parameters 5.3. Methodology 5.4. Product Competitiveness Analysis: Dental 3D Printers 6. COMPANY PROFILES 6.1. Chapter Overview 6.2. 3D Systems 6.2.1. Company Overview 6.2.2. Dental 3D Printer Portfolio 6.2.3. Recent Developments and Future Outlook 6.3. Asiga 6.4. BEGO 6.5. Carbon 6.6. Digital Wax Systems (DWS) 6.7. Formlabs 6.8. Prodways 6.9. Rapid Shape 6.10. SprintRay 6.11. Stratasys 7. PARTNERSHIPS AND COLLABORATIONS 7.1. Chapter Overview 7.2. Partnership Models 7.3. Dental 3D Printing: List of Partnerships and Collaborations 8. PATENT ANALYSIS 8.1. Chapter Overview 8.2. Scope and Methodology 8.3. Dental 3D Printing: Patent Analysis 8.4. Dental 3D Printing: Patent Benchmarking Analysis 8.5. Dental 3D Printing: Patent Valuation 8.6. Leading Patents by Number of Citations 9. BOWMAN CLOCK PRICING 9.1. Chapter Overview 9.2. Bowman Strategy Clock 9.3. Roots Analysis Framework 10. MARKET FORECAST AND OPPORTUNITY ANALYSIS 10.1. Chapter Overview 10.2. Forecast Methodology and Key Assumptions 10.3. Global Dental 3D Printing Market, 2023-2035 11. CONCLUDING REMARKS 12. APPENDIX 1: TABULATED DATA 12.1. Chapter Overview 12.2. 3DTech 12.2.1. Company Snapshot 12.3. Totustec 13. APPENDIX 1: TABULATED DATA 14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS Get more details on the Dental 3D Printing Market report https://www.rootsanalysis.com/reports/dental-3d-printing-market.html You may also be interested in the following titles: DNA Encoded Libraries mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Exosome Therapeutics Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Dental3DPrintingMarket #Dental3DPrintingMarketSize #dental3dprinting #dental3dprinter #dental3dprinters

CAR-T Cell Therapy market 2022 – Industry Growth by 2035 Roots Analysis has done a detailed study on CAR-T cell therapies, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. This report is an industry standard report and has been most awaited report from Roots Analysis. Key Market Insights  With six approved therapies and over 970 preclinical / clinical product candidates, CAR-T cell therapies represent the most active segment of the pharmaceutical domain  More than 80% of the therapy candidates, which are being developed to target a range of disease indications, are autologous in nature; CD19 and BCMA have emerged as the most popular target antigens  Several scientists from renowned universities are presently involved in clinical development efforts of CAR T cell therapies; these KOLs are primarily based in the US and China  Specifically, for CAR-T cell therapies, extensive efforts are underway to improve the CAR constructs across successive generations, involving alterations in the scFv region and using different types of gene delivery vectors  In the last 10 years, over 750 clinical trials have been registered across different geographies for CAR-T cell therapies; extensive efforts are underway to improve successive generations of therapies  Close to 200 players claim to have the required capabilities to manufacture different types of cell therapies; such firms also offer a wide range of services across different stages of product development  A rise in partnerships, in the recent past, involving both international and indigenous stakeholders, validate the growing interest in this domain; maximum number of such deals were signed in 2021  Several investors, having realized the opportunity within this upcoming segment of cancer immunotherapy, have invested USD 25 billion, across 260+ instances, during the period 2000-2022  More than 6,500 patents have been granted / filed for CAR-T cell therapies, primarily led by the non-industry players  With a growing focus on the development pipeline and encouraging clinical results, the market is anticipated to witness an annualized growth rate of over 20%, during the next decade  The projected opportunity within the CAR T cell therapy market is expected to be well distributed across key / emerging players and different geographical regions Table of Contents 1. . PREFACE 1.1. Scope of the Report 1.2. Market Segmentations 1.3. Research Methodology 1.4. Key Questions Answered 1.5. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Chapter Overview 3.2. Pillars of Cancer Therapy 3.3. Overview of Immunotherapies 3.4. Fundamentals of Cancer Immunotherapy 3.5. Classification of Cancer Immunotherapy 3.6. T-Cell Immunotherapies 3.7. Chimeric Antigen Receptor T-Cell (CAR-T) Therapy 3.8. Concluding Remarks 4. CAR-T CELL THERAPIES: MARKET LANDSCAPE 4.1. Chapter Overview 4.2. CAR-T Cell Therapies: Overall Market Landscape 4.3. CAR-T Cell Therapies: Overall Developer Landscape 5. KEY INSIGHTS 5.1. Chapter Overview 5.2. CAR-T Cell Therapies: Competitive Analysis of Popular Target Antigens 5.3. CAR-T Cell Immunotherapies: CAR Construct Analysis 6. CLINICAL TRIAL ANALYSIS 6.1. Chapter Overview 6.2. Scope and Methodology 6.3. CAR-T Cell Therapies: Clinical Trial Analysis 7. KEY OPINION LEADERS 7.1. Chapter Overview 7.2. Assumptions and Key Parameters 7.3. Methodology 7.4. CAR-T Cell Therapies: Key Opinion Leaders 8. CAR-T CELL THERAPY PROFILES 8.1. Chapter Overview 8.2. Kymriah® / Tisagenlecleucel / CTL019 (Novartis) 8.3. Yescarta® / Axiscabtagene Ciloleucel / KTE-C19 (Gilead Sciences) 8.4. Tecartus™ / Brexucabtagene Autoleucel (Gilead Sciences) 8.5. Breyanzi® / Lisocabtagene Maraleucel / JCAR017 (Bristol Myers Squibb) 8.6. Abecma™ / BB2121 / Idecabtagene Vicleucel (Bristol Myers Squibb) 8.7. Carvykti™ / Ciltacabtagene Autoleucel / LCAR-B38M CAR-T / JNJ-68284528 (Janssen) 8.8. Carteyva™ / Relmacabtagene Autoleucel / JWCAR029 (JW Therapeutics) 8.9. TBI-1501 / CD19 CAR-T Cell Therapy (Takara Bio) 8.10. AUTO1 / Obecabtagene Autoleucel / obe-cel (Autolus) 8.11. AUTO3 / CD19/22 CAR-T (Autolus) 9. PARTNERSHIPS AND COLLABORATIONS 9.1. Chapter Overview 9.2. Partnership Models 9.3. CAR-T Cell Therapies: Partnerships and Collaborations 10. FUNDING AND INVESTMENT ANALYSIS 10.1. Chapter Overview 10.2. Types of Funding 10.3. CAR-T Cell Therapies: Funding and Investment Analysis 11. PATENT ANALYSIS 11.1. Chapter Overview 11.2. Scope and Methodology 11.3. CAR-T Cell Therapies: Patent Analysis 12. CASE STUDY: CELL THERAPY MANUFACTURING 12.1. Chapter Overview 12.2. Overview of Cell Therapy Manufacturing 12.3. Cell Therapy Manufacturing Models 12.4. Scalability of Cell Therapy Manufacturing Processes 12.5. Types of Cell Therapy Manufacturers 12.6. Key Challenges Related to Manufacturing of Cell Therapies 12.7. Key Considerations for Cell Therapy Manufacturing 12.8. Automation of Cell Therapy Manufacturing Process 12.9. Cell Therapy Manufacturing Supply Chain 12.10. Comparison of Players Having In-House Capabilities and Contract Manufacturers 12.11. Regulatory Landscape 12.12. Future Perspectives 13. COST PRICE ANALYSIS 13.1. Chapter Overview 13.2. Factors Contributing to the High Price of Cell / Gene Therapies 13.3. Pricing Models for T-Cell Immunotherapies 13.4. Reimbursement related Considerations for T-cell Immunotherapies 14. MARKET FORECAST AND OPPORTUNITY ANALYSIS 14.1. Chapter Overview 14.2. Scope and Limitations 14.3. Key Assumptions and Forecast Methodology 14.4. Global CAR-T Cell Therapies Market, 2022-2035 15. PROMOTIONAL ANALYSIS 15.1. Chapter Overview 15.2. Channels Used for Promotional Campaigns 15.3. Summary of Product Website Analysis 15.4. Summary of Patient Support Services and Informative Downloads 15.5. Kymriah®: Promotional Analysis 15.6. Yescarta®: Promotional Analysis 15.7. Tecartus™: Promotional Analysis 15.8. Breyanzi®: Promotional Analysis 15.9. Abecma™: Promotional Analysis 15.10. Carvykti™: Promotional Analysis 16. COMPANY PROFILES 16.1. Chapter Overview 16.2. Alaunos Therapeutics 16.3. Autolus 16.4. Bluebird Bio 16.5. Bristol Myers Squibb 16.6. Carsgen Therapeutics 16.7. Cellectis 16.8. Cellular Biomedicine Group 16.9. Gilead Sciences 16.10. Innovative Cellular Therapeutics 16.11. Kuur Therapeutics 16.12. Noile-Immune Biotech 16.13. Novartis 16.14. Shanghai GeneChem 16.15. Sinobioway Cell Therapy 16.16. Takara Bio 16.17. Wellington Zhaotai Therapies 17. CONCLUDING REMARKS 18. EXECUTIVE INSIGHTS 18.1. Chapter Overview 18.2. Glycostem Therapeutics 18.3. TxCell 18.4. Kite Pharma 18.5. Celyad 18.6. Waisman Biomanufacturing 18.7. Theravectys 18.8. Changhai Hospital 18.9. University of Colorado 19. APPENDIX 1: TABULATED DATA 20. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html You may also be interested in the following titles: Oral Solid Dosage Manufacturing Market Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain AI-based Digital Pathology Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #cartcelltherapymarket #cartcelltherapysize #cartcelltherapy #cartcelltherapy #carttherapies

Cannabis Testing market Analysis and Trends by 2022-2035 Driven by the growing demand for medical and recreational cannabis, along with its increasing global legalization, a substantial number of product manufacturers are leveraging the expertise of testing service providers in this industry Roots Analysis has announced the addition of “Cannabis Testing Market, 2023-2035” report to its list of offerings. The report features an extensive study on the current landscape and the likely future potential of cannabis testing market over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:  An executive summary of the insights captured during our research. It offers a high-level view on the current state of the cannabis testing market and its likely evolution in the mid-long term.  A general introduction to cannabis testing, along with details related to the applications and needs for testing cannabis infused products. In addition, this section presents information on different types of testing protocols mandated by the regulatory authorities to ensure consumer safety. Further, it concludes with a discussion on the emerging trends in cannabis testing and future perspectives in this market.  A detailed assessment of the overall market landscape of cannabis testing labs based on several relevant parameters, such as year of establishment, company size (in terms of employee count), location of headquarters, type of offering(s) (cannabis testing services or cannabis testing services & products), type of company (private company or public company), number of facilities (less than 5 facilities, 5 to 10 facilities, and more than 10 facilities), type of accreditation(s) / certification(s) (ISO, PJLA, DEA, A2LA, USDA, FDA, ELAP, AOAC, CDPHE, UKAS, NCIA, NELAP, DCC, ORELAP, HIA, CLIA, ANAB ANSI, and Others), number of accreditation(s) / certification(s) (less than 5 accreditations, 5-10 accreditations, and undisclosed), type of testing solution(s) offered (potency testing, terpenes testing, microbial analysis, pesticides testing, residual solvents testing, heavy metals testing, mycotoxins testing, moisture analysis, DNA genotyping, vitamin E acetate testing, and flavonoids testing), type of sample(s) tested (edibles and infused products, cannabis buds / flowers, cannabis extracts / concentrates, and cannabis oils), type of cannabis and hemp tested (by legal status - medical cannabis, hemp, recreational / adult-use cannabis, and others), and end-user(s) (cannabis cultivators / growers, cannabis drug / product manufacturers, cannabis edible manufacturers, and other research institutes).  An insightful competitiveness analysis of cannabis testing labs based on company strength (in terms of years of experience), portfolio strength (in terms of type of company, number of facilities, type of offerings, number of testing solutions offered, number of samples tested, type of cannabis and hemp tested, and number of end-users) and number of accreditations / certifications.  Elaborate profiles of key cannabis testing labs (shortlisted based on a proprietary criterion); each profile includes a brief overview of the company, along with information on its financial information (if available), service portfolio, recent developments and an informed future outlook.  A detailed assessment of the overall market landscape of cannabis testing product providers, based on several relevant parameters, such as their year of establishment, company size (in terms of employee count), location of headquarters, type of offering(s) (cannabis testing products or cannabis testing services & products), type of testing product(s) offered (analytical instruments, consumables, reagents and additional software solutions), type of analytical instrument(s) offered (chromatography instruments, spectroscopy instruments and others), and type of additional software solution(s) offered (Laboratory Information Management System (LIMS), Customer Relationship Management (CRM), Enterprise Resource Planning (ERP)).  A detailed analysis of the partnerships that have been inked within the cannabis testing market, since 2018, based on several relevant parameters, such as year of partnership, type of partnership (mergers and acquisitions, research and development agreements, service alliances, technology integration agreements, distribution agreements, licensing agreements and other agreements), type of partner (industry and non-industry), geographical location of the companies involved, and most active players (in terms of number of partnerships).  An in-depth analysis of recent events (webinars / conferences / expos / summits) that were organized across different regions of the globe for stakeholders in this market, based on several relevant parameters, such as year of event, event platform, type of event, year and type of event, distribution of events by geography, evolutionary trends in event agenda / key focus area, most popular event organizers, most active industry players, most active non-industry players, most active speakers (in terms of number of events), details of the designation of speakers, affiliated department of event speakers and a geographical mapping of upcoming events.  One of the key objectives of the report was to estimate the current opportunity and future growth potential of cannabis testing market over the coming years. We have provided informed estimates on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of cannabis tested, type of sample tested, company size and key geographical regions. In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution. By 2035, financial opportunity within the cannabis testing market has been analyzed across the following segments:  Type of Cannabis Tested  Medical Cannabis  Recreational / Adult-use Cannabis  Type of Sample Tested  Flowers  Extracts  Edibles  Others  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa Key companies covered in the report  AccuScience Laboratories  Anresco Labs  CDX Analytics  Coastal Analytical  Eurofins Scientific  EVIO Labs  FoodChain ID  LGC  Medicine Creek Analytics  SGS  Tentamus To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/cannabis-testing-market.html You may also be interested in the following titles: Pharmaceutical Polymers / Medical Polymers Market Gene Switch Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com #CannabisTestingMarket #CannabisTestingMarketSize #cannabistesting #cannabispotencytesting #medicalcannabis

Medical Device Coatings market Analysis and Trends by 2022-2035 Driven by the growing demand of medical devices, coupled with unique coating needs for each type of medical device, an increasing number of developers are leveraging the technical expertise of coating providers in this industry Roots Analysis has announced the addition of “Medical Device Coatings Market, 2023-2035” report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of the medical device coatings and surface modification technologies in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:  A detailed executive summary of the insights captured during our research.  A detailed assessment of the current market landscape of medical device coating providers.  Detailed competitiveness analysis of various medical device coating providers.  A detailed assessment of the overall market landscape of medical device surface modification technologies and coating solutions.  Detailed product competitiveness analysis of the various surface modification technologies and coating solutions.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering medical device coatings.  An insightful analysis of the recent partnerships that have been inked within the surface modification technologies and coating solutions industry, since 2018.  An insightful analysis of the leading medical device coating providers, considering the affiliated factors, key drivers, and challenges under the PESTLE framework.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Devices Coated  Class I Medical Devices  Class II Medical Devices  Class III Medical Devices  Type of Coating Material  Polymer Coatings  Metal Coatings  Other Coatings  Company Size  Very Small  Small  Mid-sized  Large  Very Large  Key Geographical Region  North America  Europe  Asia  Rest of the World Key companies covered in the report  Advanced Coating  Biocoat  Evonik  Formacoat  Harland Medical Systems  Para-Coat Technologies  Specialty Coating Systems  SurModics  TUA Systems To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/medical-device-coatings-market.html You may also be interested in the following titles: Cell Therapy Manufacturing Market Global TCR Therapy Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #MedicalDeviceCoatingsmarket #MedicalDeviceCoatingsmarketGrowth #MedicalDeviceCoatings #antimicrobialcoatingsformedicaldevices #surfacetreatmenttechnologies

Quantum Computing market Analysis and Trends by 2022-2035 Upon realizing the numerous benefits of quantum computing, stakeholders in the pharmaceutical industry are currently exploring its implementation across drug discovery and development in order to minimize the associated cost and time investment Roots Analysis has announced the addition of “Quantum Computing in Drug Discovery Services Market, 2023-2035” report to its list of offerings. The report features an extensive study on the extensive study of the current landscape and the likely future potential of quantum computing in drug discovery services market, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:  An executive summary of the insights captured during our research. It offers a high-level view on the current state of quantum computing in drug discovery services market and its likely evolution in the short to mid and long term.  A general overview of quantum computing in drug discovery services, along with information on its types and applications across various industries. It also highlights the applications of quantum computing, specifically related to drug discovery. Further, the chapter features a discussion on the challenges, key growth drivers, and future perspectives.  A detailed assessment of the overall market landscape of quantum computing software providers, based on several relevant parameters, including year of establishment, company size, location of headquarters, business capabilities, platform capabilities, type of drug discovery service(s) offered, type of molecule(s) supported, compatible computational approaches, end user(s) and therapeutic area(s).  A detailed competitiveness analysis of quantum computing services providers based on company strength, portfolio strength and portfolio diversity.  Elaborate profiles of quantum computing software providers. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.  A detailed assessment of the overall market landscape of quantum computing hardware providers, based on several parameters including year of establishment, company size, location of headquarters, type of offering(s), data storage on cloud and compatible computational approaches.  Detailed profiles of quantum computing hardware providers. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.  A detailed review of over 170 academic grants focused on quantum computing in drug discovery, based on several relevant parameters, such as year of grants awarded, amount awarded, support period, type of study section, administering institute center, type of grant, activity code, funding mechanism and amount granted, administering institute and support period, prominent program officers (by number of grants), location of recipient organizations, popular recipient organizations, organization type and amount granted to popular recipient.  A detailed analysis of recent partnerships inked between stakeholders engaged in this domain, since 2017, based on several relevant parameters, such as year of partnership, type of partnership, most active players (in terms of number of partnerships), and regional distribution of partnership activity in this domain.  A use case study highlighting the applications of quantum computing across various industries, such as chemical industry, cybersecurity, financial modeling, space sciences, oil and gas industry and weather forecasting, and its likely evolution in the foreseen future.  A qualitative analysis, highlighting the five competitive forces prevalent in this domain, including threats for new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute product and rivalry among existing competitors.  A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market, featuring thirteen strategic tools that can help software providers to shift towards a blue ocean strategic market.  One of the key objectives of the report was to estimate the current opportunity and future growth potential of quantum computing in drug discovery services market over the coming years. We have provided informed estimates on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as drug discovery services offered, therapeutic area and key geographical regions. In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution. By 2035, financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:  Type of Drug Discovery Services  Target Identification / Validation  Hit Generation / Lead Identification  Lead Optimization  Therapeutic Area  Cardiovascular Disorders  CNS Disorders  Dermatological Disorders  Endocrine Disorders  Gastrointestinal Disorders  Immunological Disorders  Infectious Diseases  Musculoskeletal Disorders  Oncological Disorders  Respiratory Disorders  Others  Geographical Regions  North America  Europe  Asia-Pacific  Latin America  MENA Key Companies covered in the report  Accenture  Amazon Web Services  Atos  Fujitsu  Huawei  IBM  Microsoft  Xanadu  XtalPi To view more details on this report, click on the link https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html You may also be interested in the following titles: Gene Switch Market Digital Biomanufacturing Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #QuantumComputingMarket #QuantumComputingMarketSize #quantumcomputinginhealthcare #quantumcomputingindrugdiscovery #quantumcomputing

3D Bioprinting: Intellectual Property Landscape market Analysis and Trends by 2022-2035 The new market report titled ‘3D Bioprinting: Intellectual Property Landscape,’ published by Roots Analysis features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various types of 3D bioprinting. The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing trend in this domain. To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/3d-bioprinting-intellectual-property-landscape.html Main Chapters in the 3D Bioprinting Intellectual Property Landscape Report  Overall Intellectual Property Landscape An analytical perspective of the various patents and affiliated IP documents that have been published related to 3D bioprinting, since 2000. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent R&D trends within this domain.  Popular / Relevant Prior Art Search Expressions An examination of IP literature, shortlisting key words and phrases used to describe 3D bioprinting. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms and other related trends.  Patent Valuation Analysis A competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters of the patent application.  Patentability and Freedom to Operate A systematic and Roots Proprietary approach to identify relevant areas of innovation by analyzing published IP documents, by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP.  Analysis of Patent Applications and Granted 3D Bioprinting Patents A detailed summary of the various patent applications and granted patents across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of type of innovation and the innovation related to 3D bioprinting, thereby offering the means to identify active arenas of research and assess innovation-specific IP filing trends.  Pockets of Innovation and White Spaces An insightful analysis of the various CPC codes used in published IP literature and their affiliated families, offering the means to identify historical and existing pockets of innovation, the analysis also features a discussion on prevalent white spaces.  Claim Analysis One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent, type of claim and other key elements of a claim. Key Companies Profiled  Hewlett-Packard (HP)  CELLINK  Organovo  Revotek  ROKIT Healthcare  T&R Biofab  Aspect Biosystems  Prellis Biologics  Advanced Solutions Life Sciences  Cyfuse To understand the complete structure of the report, get its PDF sample copy https://www.rootsanalysis.com/reports/3d-bioprinting-intellectual-property-landscape/request-sample.html You may also be interested in the following titles: Cell Therapy Manufacturing Market Global TCR Therapy Market You may also like to learn what our experts are sharing in Roots educational series: Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Threedimensionalbioprinting #3dbioprintingpatents #3Dbioprinting #3Dbioprintinginvestments #3DbioprintingIPlandscape

Spatial Genomics, Transcriptomics and Proteomics Solutions market Analysis and Trends by 2022-2035 Recent advancements in multiplexed profiling and tissue imaging methods have enabled the assessment of spatial heterogeneity in intact tissues; as a result, adoption of spatial omics solutions offering benefits over traditional methods, is increasing Roots Analysis has announced the addition of “Spatial Genomics, Transcriptomics and Proteomics Solutions Market, 2022-2035” report to its list of offerings. The Spatial Genomics Market report features an extensive study of the current market landscape and the likely future potential; associated with the spatial omics solutions market, over the next decade. The study also includes a detailed analysis of key drivers and trends within this evolving market. Amongst other elements, the report features:  A detailed overview of the overall market landscape of spatial omics solutions based on several relevant parameters.  A detailed overview of the overall market landscape of players engaged in offering spatial proteomics, transcriptomics and genomics solutions, based on year of establishment, company size, location of headquarters and regional landscape.  A detailed competitiveness analysis of products based on parameters, such as supplier power and product specifications.  Elaborate profiles of key players offering spatial omics solutions.  An analysis of the various partnerships related to spatial omics solutions inked by players engaged in this domain.  An in-depth analysis of patents related to spatial omics solutions, filed / granted, since 2003.  A detailed review of around 600 peer-reviewed, scientific articles related to research on spatial omics solutions.  An elaborate discussion on the various commercialization strategies that can be adopted by drug developers engaged in this domain, across different stages of therapy development, including prior to drug launch, at / during drug launch and post-marketing of the drug.  A detailed review of the overall landscape of the live cell instruments market, highlighting the contributions of industry players, along with information on their year of establishment, company size, geographical location of headquarters, ownership and instruments specific parameters.  A detailed review of the overall landscape of sequencing technologies market, highlighting the contributions of industry players, along with information on their year of establishment, company size, geographical location of headquarters, ownership and sequencers specific parameters.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Solution  Instruments  Consumables  Services  Sample Type  DNA  RNA  Protein  Research Area  Oncological Disorders  Immunological Disorders  Neurological Diorders  Infectious Diseases  Others  End User  Pharmaceutical and Biotechnology Companies  Academic and Research Institutes  Key Geographical Regions  North America  Europe  Asia-Pacific and Rest of the World Key companies covered in the report  10x Genomics  Akoya Biosciences  Bruker  Canopy Biosciences  NanoString Technologies  Vizgen  Lunaphore Technologies  Molecular Machines & Industries (MMI)  Resolve Biosciences To view more details on this report, click on the link https://www.rootsanalysis.com/reports/spatial-genomics-market.html You may also be interested in the following titles: Cannabis Testing Market Decentralized Clinical Trials / Virtual Clinical Trials Market You may also like to learn what our experts are sharing in Roots educational series: At-home Self-testing: A Giant Leap Towards Transformation in Diagnostic Sector SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #SpatialGenomics #SpatialGenomicsMarket #SpatialGenomicsMarketSize #SpatialGenomicsTrends #spatialtranscriptomics